Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in March 2009 on request of the sponsor.
On 26 January 2005, orphan designation (EU/3/04/259) was granted by the European Commission to Zambon Group S.p.A, Italy, for acetylcysteine for the treatment of idiopathic pulmonary fibrosis.
|Disease / condition||
Treatment of idiopathic pulmonary fibrosis
|Date of first decision||
|EU designation number||
Sponsor's contact details
Via Lillo del Duca, 10
I-091 Bresso, Milan
Telephone: +39 02 66 52 41
Telefax: +39 02 66 50 14 92
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.